According to the Next Day Disclosure Return submitted on 20 October 2025, C-MER Medical Holdings Limited (stock code: 03309) reported updates to its shareholding structure. As of the opening balance on 17 October 2025, 1,242,976,870 issued shares were outstanding (excluding treasury shares), while 12,584,000 were held as treasury shares.

On 20 October 2025, 200,000 shares were repurchased on the market at an approximate price of HKD 1.9095 per share, and these repurchased shares were added to the company’s treasury. Following this transaction, the updated numbers show 1,242,776,870 issued shares outstanding (excluding treasury shares) and a total of 12,784,000 treasury shares, resulting in 1,255,560,870 shares overall.

The announcement also details a series of share repurchases conducted since July 2024 for cancellation but not yet canceled, with multiple transactions occurring on various dates between July 2024 and May 2025 at different prices. The company notes these transactions remain pending cancellation but are already reflected as repurchases. No new issues or transfers of these treasury shares are reported within 30 days of the latest repurchase, in accordance with the company’s repurchase mandate approved on 19 May 2025.